Gallagher Named Associate Dean for Graduate Studies at IU School of Medicine
June 22, 2011
INDIANAPOLIS --
Patricia J. Gallagher, Ph.D., professor of cellular and integrative physiology, has been named associate dean for graduate studies at the Indiana University School of Medicine.
Dr. Gallagher, who joined the School of Medicine faculty in 1992, succeeds Simon Rhodes, Ph.D., who has been named dean of the IUPUI School of Science. Dr. Gallagher’s appointment as associate dean for graduate studies is effective July 1.
In her research, Dr. Gallagher has focused on the molecular pathways that affect the cellular systems controlling cell death, or apoptosis, with the goal of using such information to design therapies to kill cells that are undergoing unregulated proliferation, such as cancer cells or vascular smooth muscle cells that replicate to block a blood vessel.
She received her doctorate from New York Medical College and served postdoctoral fellowships at Cold Spring Harbor Laboratory in New York and at the University of Texas Southwestern Medical Center in Dallas.
She is a member of the Indiana University Melvin and Bren Simon Cancer Center.
Related Articles
November 12, 2010 -- Twenty-one physicians with the Indiana University School of Medicine have been recognized as the best in their field.
September 15, 2011 -- Internationally recognized cancer researcher Murray Korc, M.D., will join the Indiana University Melvin and Bren Simon Cancer Center as the first Myles Brand Professor of Cancer Research on Oct. 1.
January 20, 2012 -- Linda K. Han, M.D., has been named professor of clinical surgery at the Indiana University School of Medicine and director of the Indiana University Melvin and Bren Simon Cancer Center Breast Surgical Oncology program.
October 23, 2012 -- Scientists are now a step closer to understanding the complexities of breast cancer with findings made available through The Cancer Genome Atlas, a multi-center study funded by the National Institutes of Health. Indiana University School of Medicine participated in the research that identified four molecular cancer subtypes based on samples from 825 breast cancer patients.
